Photo from wikipedia
2-deoxy-2[18F]fluoro-D-glucose (FDG) positron emission tomography-computed tomography (PET-CT) has revolutionised oncological imaging. The cellular processes that make cancer cells visible on FDG PET-CT, also occur in a wide range of inflammatory… Click to show full abstract
2-deoxy-2[18F]fluoro-D-glucose (FDG) positron emission tomography-computed tomography (PET-CT) has revolutionised oncological imaging. The cellular processes that make cancer cells visible on FDG PET-CT, also occur in a wide range of inflammatory cells; exploiting this phenomenon has led to a growth of evidence supporting the use of FDG PET-CT in a wide range of infective and inflammatory diseases. Rheumatological diseases can affect multiple sites within the musculoskeletal system alongside multi-organ extra-articular disease manifestations. Inflammation is central to these diseases, making FDG PET-CT a logical choice. In this review article, we will describe the various applications of FDG PET-CT in rheumatological diseases using illustrative examples to highlight the beneficial role of FDG PET-CT in each case.
Journal Title: Rheumatology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!